A detailed history of Wealth Quarterback LLC transactions in Mainz Biomed N.V. stock. As of the latest transaction made, Wealth Quarterback LLC holds 10,000 shares of MYNZ stock, worth $2,100. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,000
Holding current value
$2,100
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$0.38 - $1.13 $3,800 - $11,299
10,000 New
10,000 $4,000

Others Institutions Holding MYNZ

About MAINZ BIOMED N.V.


  • Ticker MYNZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 14,483,000
  • Market Cap $3.04M
  • Description
  • Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments...
More about MYNZ
Track This Portfolio

Track Wealth Quarterback LLC Portfolio

Follow Wealth Quarterback LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Quarterback LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Quarterback LLC with notifications on news.